Increased activated protein C: Protein C inhibitor complex and decreased protein C inhibitor levels in patients with chronic renal failure on maintenance hemodialysis

Clinical and Applied Thrombosis/Hemostasis

Volumn 5, Issue 2, 1999, Pages 113-116

  Takagi, Mikio ^a   Wada, Hideo ^b   Mukai, Kenji ^a   Minamikawa, Kouzou ^c   Wakita, Yoshihiro ^b   Deguchi, Katsumi ^a   Junji, Nishioka ^b   Hayashi, Tatsuya ^b   Suzuki, Koji ^b   Shiku, Hiroshi ^a  

^a Ise General City Hospital   (Japan)

^b MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NONE

Author keywords

APC PCI complex; APC 1AT complex; Hemodialysis

Indexed keywords

ACTIVATED PROTEIN C; ALPHA 1 ANTITRYPSIN; ANTIPLASMIN; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 3; PROTEIN S; THROMBIN ANTITHROMBIN COMPLEX; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

EID: 0032890703     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602969900500207     Document Type: Article

References (26)

1. Bruton BT, Kruegar KK, Bryan FA. National registry of longterm dialysis patients. JAMA 1971;218:718.
2. Brunner FP, Brynger H, Chantier C, et al. Combined report on regular dialysis and transplantation in Europe IX, 1978. In: Robinson BHB, Howkins JB, Naik RB, eds. Proceedings of the European Dialysis and Transplant Association 1979:7.
3. Deguchi K, Izumi K, Noguchi M, et al. Coagulation and fibrinolysis in patients with chronic renal failure on maintenance hemodialysis. Acta Haematol JPN 1989;52:140.
4. Griffin JH, Evatt B, Zimmerman T, et al. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981;68:1370.
5. Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984;74:2082.
6. Esmon CT. The regulation of natural anticoagulant pathways. Science 1987;235:1348.
7. Pelzer H, Schwarz A, Heinburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 1987;59:101.
8. Mimuro J, Koike Y, Sumi Y, Aoki N. Monoclonal antibodies to discrete regions in α2-plasmin inhibitor. Blood 1987;69:446.
9. Marlar RA, Endres-Brook J, Miller C. Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation. Blood 1985;66:59.
10. Tabernero D, Espana F, Vicente V, et al. Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatment. Thromb Haemost 1990;63:380.
11. Gruber A. Griffin JH. Direct detection of activated protein C blood from human subjects. Blood 1992;79:2340.
12. Orthner CL, Kolen B, Drohan WN. A sensitive and facile assay for the measurement of activated protein C activity levels in vivo Thromb Haemost 1993;69:441.
13. Asakura H, Saito M, Ito K, et al. Levels of thrombin-antithrombia III complex in plasma in cases of acute promyelocytic leukemia Thromb Res 1988;50:895.
14. Suzuki K, Nishioka J, Hashimoto S. Protein C inhibitor. Purification from human plasma and characterization. J Biol Chem 1983; 258:163.
15. Suzuki K, Stenflo J, Dahlback B. Inactivation of human coagulation V by activated protein C. J Biol Chem 1983;258:1914.
16. Suzuki K, Nishioka J, Hashimoto S, et al. Normal titer of functional and immunoreactive protein C inhibitor in plasma of patient with congenital combined deficiency of factor V and factor VIII Blood 1983;62:1266.
17. Suzuki K. Biochemistry and Physiology of protein C inhibitor. In Witt I, ed. Protein C-Biochemical and Medical Aspects. Berlin Walter de Gruyter, 1985:43.
18. Esmon CT. The regulation of natural anticoagulant pathways. Science 1987;235:1348.
19. Broekmana AW, Veltkamp JJ, Bertina RM. Congenital protein C deficiency and venous thrombo-embolism. A study of three Dutch families. New Engl J Med 1983;309:340.
20. Kisiel W. Human plasma protein C: Isolation, characterization and mechanism of activation by thrombin. J Clin Invest 1979;64:761.
21. Owen WG, Esmon CT. Functional properties of an endothelial cell cofactor for thrombin catalyzed activation of protein C. J Bio Chem 1981;256:5532.
22. Marlar RA, Griffin JH. Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease. J Clin Invest 1980;66:1186.
23. van der Meer FJM, van Tilburg NH, van Wijngaarden, et al. A second plasma inhibitor of activation protein C: α1 antitrypsine Thromb Haemost 1989;63:756.
24. Heeb MJ, Gruber A, Griffin JH. Metal ion-dependent inhibitional activated protein C (APC) by α2 macroglobulin and α2 antiplasmin in human blood. J Biol Chem 1991;266:17606.
25. Espana F, Griffin JH. Determination of functional and antigem protein C inhibitor and its complexes with activated protein C in plasma by Elisa's. Thromb Res 1989;55:671.
26. Espana F, Vicente V, Tabernero D, et al. Determination of plasm. protein C inhibitor and of two activated protein C-inhibitor complexes in normals and in patients with intravascular coagulation and thrombotic disease. Thromb Res 1990;59:593.